-79% Off

Buy Xtandi (Enzalutamide) from Canada

Original price was: $19,677.94.Current price is: $4,100.99.

Xtandi, also known by its generic name enzalutamide, is a prescription medication primarily indicated for the treatment of advanced prostate cancer. This type of cancer often develops resistance to conventional hormone therapy, necessitating alternative approaches.

- +
Compare
Category:

Description

40 mg 120 Capsules

Xtandi, also known by its generic name enzalutamide, is a prescription medication primarily indicated for the treatment of advanced prostate cancer. This type of cancer often develops resistance to conventional hormone therapy, necessitating alternative approaches. Xtandi falls under the category of androgen receptor inhibitors, operating by targeting and obstructing the action of androgens – male hormones that stimulate the growth of prostate cancer cells.

This medication is meticulously crafted to address cases of metastatic castration-resistant prostate cancer (mCRPC). This advanced stage emerges when cancer cells persist in growing despite reduced testosterone levels, a hormone typically suppressed in prostate cancer treatment. Xtandi emerges as a beacon of hope for those confronted with mCRPC, offering an efficacious avenue to manage the disease’s advancement.

Xtandi’s effectiveness hinges on its capacity to disrupt the androgen signaling pathway. Prostate cancer cells thrive on androgens, which invigorate their growth. Xtandi functions by binding to androgen receptors on these cells, preventing androgens from attaching and thus impeding the signals that propel cancer cell growth. This targeted intervention curbs the cancer’s capacity to spread and effectively moderates its progression.